Seres Therapeutics, Inc. Public Float
Seres Therapeutics, Inc. (MCRB) had Public Float of $71.94 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $71.94M.
- 2024-06-28: Entity Public Float $87.10M.
- 2023-06-30: Entity Public Float $463.03M.
- 2022-06-30: Entity Public Float $239.92M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $71.94M 10-K · filed 2026-03-12 |
| 2024-06-28 | $87.10M 10-K · filed 2025-03-13 |
| 2023-06-30 | $463.03M 10-K · filed 2024-03-05 |
| 2022-06-30 | $239.92M 10-K · filed 2023-03-07 |
| 2021-06-30 | $1.65B 10-K · filed 2022-03-01 |
| 2020-06-30 | $219.85M 10-K · filed 2021-03-02 |
| 2019-06-28 | $132.30M 10-K · filed 2020-03-02 |
| 2018-06-29 | $177.05M 10-K · filed 2019-03-06 |
| 2017-06-30 | $229.70M 10-K · filed 2018-03-08 |
| 2016-06-30 | $570.58M 10-K · filed 2017-03-16 |
| 2015-06-30 | $422.40M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |